Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study.

J Clin Med · 2024 · PMC11012715 · PMID 38610687

Europe PMC DOI

hedged sentence

0.3480

closest p · 7.0× alpha

0.3480

boldest claim

The sentences

did not reach statistical significancep = 0.348not close (p > 0.1)

Comorbidity and Complications Associated with T1D Differences in acute decompensation cumulative incidence among those with or without COVID-19 infection did not reach statistical significance: acute hyperglycemic decompensation, 3/71 (4.2%) and 7/85 (8.2%), respectively ( p = 0.348); acute hypoglycemic decompensation, 3/71 (4.23%) and 6/85 (7.1%), respectively ( p = 0.511).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.